Cargando…
Diagnostisches und therapeutisches Vorgehen bei Sarkopenie
Sarcopenia describes a generalized loss of muscle power, mass and function. It is marked by an impaired quality of life and an increased mortality rate. The SARC‑F questionnaire was developed as a screening tool to identify patients at risk of impairment in primary care. It addresses five functional...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450554/ https://www.ncbi.nlm.nih.gov/pubmed/34542697 http://dx.doi.org/10.1007/s00391-021-01968-7 |
_version_ | 1784569673969303552 |
---|---|
author | Schaupp, Anna Martini, Sebastian Schmidmaier, Ralf Drey, Michael |
author_facet | Schaupp, Anna Martini, Sebastian Schmidmaier, Ralf Drey, Michael |
author_sort | Schaupp, Anna |
collection | PubMed |
description | Sarcopenia describes a generalized loss of muscle power, mass and function. It is marked by an impaired quality of life and an increased mortality rate. The SARC‑F questionnaire was developed as a screening tool to identify patients at risk of impairment in primary care. It addresses five functional areas of physical activity in daily life. In case of a relevant impairment this is to be followed by measurement of hand grip strength using a dynamometer and/or of leg muscle strength by the chair rising test. Patients with pathological results should undergo a measurement of the skeletal muscle index, e.g. by Dual-energy X‑ray Absorptiometry. If this lies below the gender-specific threshold, the diagnostic criteria for sarcopenia are met. Cases with normal lean muscle mass are coined as probable sarcopenia. In both cases, causes must be clarified and treatment should be initiated. To differentiate between acute and chronic sarcopenia it is necessary to assess disease progress after a certain period of time. |
format | Online Article Text |
id | pubmed-8450554 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Medizin |
record_format | MEDLINE/PubMed |
spelling | pubmed-84505542021-09-20 Diagnostisches und therapeutisches Vorgehen bei Sarkopenie Schaupp, Anna Martini, Sebastian Schmidmaier, Ralf Drey, Michael Z Gerontol Geriatr CME Sarcopenia describes a generalized loss of muscle power, mass and function. It is marked by an impaired quality of life and an increased mortality rate. The SARC‑F questionnaire was developed as a screening tool to identify patients at risk of impairment in primary care. It addresses five functional areas of physical activity in daily life. In case of a relevant impairment this is to be followed by measurement of hand grip strength using a dynamometer and/or of leg muscle strength by the chair rising test. Patients with pathological results should undergo a measurement of the skeletal muscle index, e.g. by Dual-energy X‑ray Absorptiometry. If this lies below the gender-specific threshold, the diagnostic criteria for sarcopenia are met. Cases with normal lean muscle mass are coined as probable sarcopenia. In both cases, causes must be clarified and treatment should be initiated. To differentiate between acute and chronic sarcopenia it is necessary to assess disease progress after a certain period of time. Springer Medizin 2021-09-20 2021 /pmc/articles/PMC8450554/ /pubmed/34542697 http://dx.doi.org/10.1007/s00391-021-01968-7 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | CME Schaupp, Anna Martini, Sebastian Schmidmaier, Ralf Drey, Michael Diagnostisches und therapeutisches Vorgehen bei Sarkopenie |
title | Diagnostisches und therapeutisches Vorgehen bei Sarkopenie |
title_full | Diagnostisches und therapeutisches Vorgehen bei Sarkopenie |
title_fullStr | Diagnostisches und therapeutisches Vorgehen bei Sarkopenie |
title_full_unstemmed | Diagnostisches und therapeutisches Vorgehen bei Sarkopenie |
title_short | Diagnostisches und therapeutisches Vorgehen bei Sarkopenie |
title_sort | diagnostisches und therapeutisches vorgehen bei sarkopenie |
topic | CME |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450554/ https://www.ncbi.nlm.nih.gov/pubmed/34542697 http://dx.doi.org/10.1007/s00391-021-01968-7 |
work_keys_str_mv | AT schauppanna diagnostischesundtherapeutischesvorgehenbeisarkopenie AT martinisebastian diagnostischesundtherapeutischesvorgehenbeisarkopenie AT schmidmaierralf diagnostischesundtherapeutischesvorgehenbeisarkopenie AT dreymichael diagnostischesundtherapeutischesvorgehenbeisarkopenie |